Abstract
Background: Triple-negative breast cancer (TNBC) is an aggressive phenotype with bad prognosis and poor survival. The prognostic and predictive values of BRCA1-Iris, octamer-binding transcription factor 4 (oct 4), cyclin D1andsurvivin were assessed in TNBC patients compared with N-TNBC patients. Method: RNA expression levels of BRCA1-IRIS, Oct4, Cyclin D1 and Survivin gene were tested in for 100 breast cancer patients by qRT-PCR. Result: overexpression ofBRCA1-IRIS RNA was found in 49 % of breast cancer patients [(35(71 %) of TNBC cases vs 14(28.6% of N-TNBC] (p < 0.001). There was significantly correlated between the BRCA1-IRIS and tumor stage, ER and PR (p=0.036, p < 0.001 and p=0.006; respectively) in breast cancer patients. In TNBC or N-TNBC, no statistically significance between BRCA1-IRIS and any clinicopathological features of patients. There was significant association between BRCA1-IRIS positive and the expression of oct4, cyclin D1 and survivin gene in TNBC patients (p < 0.001, p=0.001 and p=0.002; respectively). There was a strong significant correlation between the expression of oct4 and the BRCA1-IRIS negative (p < 0.001) in TNBC group. No significant association between BRCA1-IRISpositive in N-TNBC and any of the gene expression. BRCA1-IRISnegative was correlated significantly with oct4 and cyclin D1expression (p=0.001each).No significant correlation between the expression RNA level of oct4, cyclin D1 and survivin gene and the expression RNA level of BRCA1-IRIS except lymphnode with survivin gene expression (p=0.05). No significant relation between the expression level of oct4, cyclin D1 and survivin gene and the relevant clinicopathological features with or without BRCA1-IRIS expression. Expression level of survivin and cyclin D1 was significantly correlation with the response to treatment (p=0.001 and p < 0.001). No significant different between overall survival and BRCA1-IRIS expression (p=0.291 long rang). However, disease-free survival was increased in BRCA1-IRIS positive cases (p = 0.052 long rang)
Highlights
Breast cancer is the most type of cancer in women in either developed or less developed countries
The expression of BRCA1IRIS, Oct4, Cyclin D1 and Survivin was assessed in the two studied groups and the relations with the clinic-pathological features of patients as well as to demonstrate the response to treatment
BRCA1-IRIS gene was expressed in 35 (71.4%) in Triple negative breast cancer (TNBC) patients compared to 14(28.6%) patients in N-TNBC
Summary
El-Rouby, Abeer Bahnassy Department of Cancer Biology, Virology and Immunology Unit, National Cancer. Department of parasitology Faculty of science, Al Azhar university (Girls branch) Cairo, Egypt. Molecular Pathology, National Cancer Institute, Cairo University, Egypt
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
